The federal government is reportedly going after an apartment company with thousands of rental properties in metro Atlanta.

The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.

The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.

Representative Ben Cline (R-VA) says the One Agency Act would house all antitrust authority under the Department of Justice. ...

The IFA has formally called on the Federal Trade Commission to shift its focus away from increased regulation of the franchise business model, arguing that the commission's recent actions exceed its ...

Financial business leaders converged on the University of Miami to discuss the regulatory and political landscape expected ...

Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity-drug maker tumbled after it slashed its projection for fourth-quarter revenue as the market for drugs that ...

A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.

The U.S. Federal Trade Commission has prepared a lawsuit against Deere & Co alleging the company's agricultural equipment ...